Paul Taylor (University of Leeds) announced on Twitter on Oct. 5, 2018 that a drug identified "thanks to fruit flies" is now in clinical trials as a potential treatment for lung cancer. A Drosophila chemical genomics research study in which the compound was identified was published in 2017 in Cancer Letters and can be viewed here. Coverage from a business perspective is available at proactiveinvestors.co.uk and include this post on US patent approval.